Compares gout crystal deposits with heart artery plaque using CT scans
Studies whether gout urate deposits in the foot relate to plaque in heart arteries.
Plain-language title generated from the registry record
Registry title: The Correlation Between Sodium Urate (MSU) Deposition and Coronary Atherosclerosis in Patients With Foot Gout
Key facts
- Where
- Qingdao, ChinaSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with gout in the foot who also have high-risk factors for heart disease. It studies urate deposits and plaque in the heart arteries using CT scans.
- Age
- 18 to 90 years
- Sex
- Men and women can join.
- Disease stage
- Gout in the foot (podagra) diagnosed by a doctor, with high-risk factors for cardiovascular disease.
Main reasons for not taking part
- Women who are planning pregnancy, pregnant or breastfeeding
- Men and women of reproductive age who cannot use effective contraception
- People who cannot have a CTA scan
- Severe heart disease such as severe heart failure, severe heart valve disease or cardiomyopathy
- Severe unstable blood circulation (hemodynamic instability)
Read by machine on 12 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 90 years old?
Source: NCT07784049, who can take part
Where in China
- The Affiliated Hospital of Qingdao UniversityQingdao, ChinaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- The Affiliated Hospital of Qingdao University
- Trial code
- NCT07784049
- Record updated
- 25 August 2026
- Original description
This observational study aims to evaluate the association between sodium urate deposition volume and coronary atherosclerotic plaques in patients with foot gout using dual-energy CT (DECT) and coronary CTA. This study will explore imaging-based evidence for the progression and risk prediction of adverse cardiovascular events in patients with gout.Read full original descriptionShow less
Affiliated Hospital of Qingdao University
This observational study aims to evaluate the association between sodium urate deposition volume and coronary atherosclerotic plaques in patients with foot gout using dual-energy CT (DECT) and coronary CTA. This study will explore imaging-based evidence for the progression and risk prediction of adverse cardiovascular events in patients with gout.
Inclusion: Aged ≥18 years, male or female; Clinically diagnosed with podagra; Having high-risk factors for cardiovascular disease; Complete clinical data available; Patients and their family members are informed, consent and have signed the informed consent form.
Exclusion: Patients with severe heart diseases such as severe heart failure, severe heart valve disease and cardiomyopathy; Male and female subjects of reproductive age who are unable to take effective contraceptive measures; Women who are preparing for pregnancy, pregnant or breastfeeding; Patients who cannot or are unable to undergo CTA scans; Severe hemodynamic instability; Any other reason making subjects unsuitable to participate in the study, including subjects who are unable or unwilling to comply with the requirements of the study protocol.